{"abstract":"This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i), that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant to Nova Therapeutics LLC of a start-up exclusive commercialization license to practice the inventions embodied in the following US Provisional Patent Application (and all domestic and foreign counterparts claiming priority to it): Serial No. 61/651,961, filed May 25, 2012, entitled, \"Methods of Regulating Cannabinoid Receptor Activity-related Disorders and Diseases\" [HHS Ref. E-139-2012/0-US-01]. The patent rights in this invention have been assigned to the Government of the United States of America. The prospective start-up exclusive commercialization license territory may be worldwide, and the field of use may be limited to:","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2013/04/05/2013-07907.html","cfr_references":[],"citation":"78 FR 20671","comment_url":null,"comments_close_on":"2013-04-22","correction_of":null,"corrections":[],"dates":"Only written comments or applications for a license (or both) which are received by the NIH Office of Technology Transfer on or before April 22, 2013 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2013-07907","effective_on":null,"end_page":20672,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2013/04/05/2013-07907.xml","html_url":"https://www.federalregister.gov/documents/2013/04/05/2013-07907/prospective-grant-of-a-start-up-commercialization-exclusive-license-the-development-of-fenoterol","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2013-07907?publication_date=2013-04-05","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2013-04-05/2013-07907/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":48,"last_updated":"2026-10-25 14:15:05 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2013-04-05/pdf/2013-07907.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2013-07907.pdf?1365080444","publication_date":"2013-04-05","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2013/04/05/2013-07907.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=NIH_FRDOC_0001","supporting_documents_count":0,"docket_id":"NIH_FRDOC_0001","regulation_id_number":null,"title":"Recently Posted NIH Rules and Notices.","checked_regulationsdotgov_at":"2013-04-25T08:06:01Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":20671,"subtype":null,"title":"Prospective Grant of A Start-Up Commercialization Exclusive License: The Development of Fenoterol Analogues for the Treatment of Brain and Hepatocellular Cancers","toc_doc":"Development of Fenoterol Analogues for Treatment of Brain and Hepatocellular Cancers","toc_subject":"Prospective Grant of a Start-Up Commercialization Exclusive License:","topics":[],"type":"Notice","volume":78}